Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itraconazole in superficial fungal infections in India
NCT03923010Phase 4Terminated
- Sponsor
- Janssen Pharmaceutical
- Start
- Aug 2019
- Primary completion
- Mar 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of itraconazole in Tinea cruris (TC), tinea corporis, sponsored by Janssen Pharmaceutical. Started Aug 2019; status: terminated.
02
Drugs
itraconazole
03
Conditions
Tinea cruris (TC)tinea corporis
Beyond the preview
Go deeper on NCT03923010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03923010.